drugset / Trial / NCT00016146
Vaccine Therapy Plus Biological Therapy in Treating Patients With Prostate Cancer
Phase 1
Completed
34 enrolled
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI) · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
RATIONALE: Vaccines may make the body build an immune response to kill tumor cells. Biological therapies use different ways to stimulate the immune system and stop cancer cells from growing. Combining vaccine therapy with biological therapy may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness in combining vaccine therapy and biological therapy in treating patients who have relapsed prostate cancer.
Timeline
- Start
- 2000-07
- Primary completion
- 2009-03
- Completion
- 2009-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GPI-0100 | Other / unclassified | — | Subcutaneous |
| Subject | MUC-2-Globo H-KLH conjugate vaccine | Vaccine | — | Subcutaneous |